U.S. Interactive Media and Services Stock News

NYSE:QGEN
NYSE:QGENLife Sciences

Is Qiagen's (QGEN) Digital PCR Expansion Quietly Redefining Its Competitive Moat in Biopharma Tools?

In mid-June 2026, QIAGEN N.V. expanded its QIAcuity digital PCR ecosystem with new gene expression assays, high-multiplex PCR kits, enhanced residual DNA testing, upgraded analysis software and increased automation options for life sciences and biopharma users. This build-out deepens the integration between QIAcuity instruments, GeneGlobe assay content, and automated workflows, potentially making digital PCR more accessible and standardized for high-throughput and regulated...
NYSE:MAC
NYSE:MACRetail REITs

Is Macerich (MAC) Fully Valued As Its Shares Climb And Valuation Views Split?

Recent Price Moves Put Macerich Back on Investor Radars Macerich (MAC) has moved sharply in recent trading, with the stock up 4.2% on the day and posting double digit gains over the past week, month, and past 3 months. See our latest analysis for Macerich. At a share price of $25.41, Macerich sits on a year to date share price return of 37.2% and a 1 year total shareholder return of 66.21%, suggesting momentum has been building over both shorter and longer periods. If you are looking beyond...
NasdaqGS:ATRO
NasdaqGS:ATROAerospace & Defense

Why Astronics (ATRO) Is Up 5.3% After Stock Split And Investor Conference Spotlight - And What's Next

Astronics Corporation recently completed a 1.2-for-1 stock split on June 15, 2026, and presented at the Truist Securities Industrials and Services Conference at the Boston Harbor Hotel in New York on June 16, 2026, enhancing visibility among aerospace and defense industry stakeholders. The combination of stronger revenue and earnings performance with increased conference exposure has drawn renewed attention to Astronics’ execution and market position in aerospace technologies. We’ll now...
NYSE:AXP
NYSE:AXPConsumer Finance

American Express (AXP) Stock Weighs Strong Returns Against Mixed Valuation Signals

If you are wondering whether American Express stock still offers value at recent levels, this article walks through what the current price really reflects and how that lines up with different valuation checks. American Express last closed at US$342.56, with returns of 0.6% over the past week, 9.9% over the past month, a decline of 8.1% year to date, and gains of 12.2% over 1 year, 109.1% over 3 years, and 120.3% over 5 years. Recent coverage has focused on American Express as a large,...
NasdaqGM:IOVA
NasdaqGM:IOVABiotechs

3 US Growth Stocks Analysts Back For Strong Earnings Expansion

With inflation, interest rates and global growth expectations all pulling markets in different directions, many investors are looking for companies where analysts still see clear earnings growth and balance sheets that can support it. The Healthy high growth potential screener focuses on exactly that. It highlights stocks where analysts expect earnings expansion over the next 3 years, alongside an acceptable financial position. In this article, three of the best stocks from this screener will...
NYSE:DIS
NYSE:DISEntertainment

Disney (DIS) Lands 2026’s Biggest Opening As ABC Fight Adds Fresh Risk

Disney (NYSE:DIS) reports a record opening for Toy Story 5, marking the biggest movie debut of 2026 and of the franchise. The company sees contrasting film results, with its latest Star Wars release underperforming at the box office. Disney rolls out a new CTV advertising partnership with Omnicom Media and Innovid, targeting more tailored ads and tighter frequency controls. Regulatory and political tension increases as ABC contests FCC license reviews linked to diversity programs and faces...
NYSE:O
NYSE:ORetail REITs

Is Realty Income (O) Still Below Fair Value Or Is Its Dividend Appeal Priced In?

Realty Income (O) continues to attract income focused investors, as the company emphasizes its role as a full service real estate capital provider with a global portfolio and a long history of monthly dividend payments. See our latest analysis for Realty Income. At a recent share price of $61.99, Realty Income has recorded a 1 day share price return of 0.75% and a year to date share price return of 8.17%, while its 1 year total shareholder return of 14.66% points to momentum that reflects...
NasdaqCM:FRHC
NasdaqCM:FRHCCapital Markets

Freedom Holding (FRHC) Looks Expensive, Is The Premium Already Priced In?

How Freedom Holding Stock Has Been Trading Freedom Holding (FRHC) has drawn attention after recent share price moves, with the stock closing at US$135.45 and showing mixed returns over different periods, including gains year to date and declines in the past month and past 3 months. See our latest analysis for Freedom Holding. Recent trading suggests momentum for Freedom Holding has cooled, with the share price down over the past month and quarter but still ahead year to date, while longer...
NYSE:NMM
NYSE:NMMShipping

Navios Maritime Partners (NMM) Draws Undervalued Interest, Is More Upside Still Available?

Navios Maritime Partners (NYSE:NMM) has drawn investor attention after recent trading, with the stock closing at $71.19. The move comes against a backdrop of mixed short term returns and strong longer term performance metrics. See our latest analysis for Navios Maritime Partners. Recent trading has been softer, with a 1-day share price return of 1.85% and a 30-day share price return of 4.47%. However, Navios Maritime Partners still shows a 90-day share price return of 7.21% and a 1-year total...
NYSE:COMP
NYSE:COMPReal Estate

Why Compass (COMP) Is Up 13.3% After Settling A Major TCPA Class-Action Lawsuit – And What's Next

Earlier this week, Compass (NYSE: COMP) reached a settlement in a Telephone Consumer Protection Act class-action lawsuit, resolving a major legal dispute that had posed potential financial and operational risks. This resolution removes a key legal overhang that had been clouding Compass's outlook, freeing management to focus more squarely on its core real estate technology platform and service expansion. We’ll now examine how clearing this legal overhang may affect Compass’s investment...
BATS:CBOE
BATS:CBOECapital Markets

3% Premium Or Deeper Value? Cboe Global Markets (CBOE) After A Split Valuation View

Recent Performance Snapshot for Cboe Global Markets Cboe Global Markets (CBOE) has drawn investor attention after a mixed stretch for the stock, with recent returns weaker over the past month and past 3 months while longer term performance remains positive. The stock closed at US$249.59, with the price down 3% over the past day, 2% over the past week, about 30% over the past month and nearly 11% over the past 3 months, while the 1 year total return is 9.47%. See our latest analysis for Cboe...
NYSE:GLOB
NYSE:GLOBIT

Globant (GLOB) Could Be 42% Undervalued Following Its AI Services Narrative

Globant (GLOB) has seen its stock price come under pressure recently, with the shares down 27% over the past month and 36% over the past 3 months. This has prompted fresh attention from investors tracking technology services companies. See our latest analysis for Globant. Beyond the recent selloff, Globant’s share price return has declined 53.83% year to date and the 1 year total shareholder return has fallen 67.24%. This signals fading momentum that reflects changing market expectations...
NasdaqGM:SPRY
NasdaqGM:SPRYBiotechs

ARS Pharmaceuticals (SPRY) Misses Neffy Coverage Expansion, Is The Stock Still Cheap?

ARS Pharmaceuticals (SPRY) told investors that its Neffy nasal spray did not gain expanded commercial insurance coverage in the July 1 review cycle, a setback that immediately weighed on expectations for the product’s market reach. See our latest analysis for ARS Pharmaceuticals. The setback on Neffy coverage comes after a sharp move in ARS Pharmaceuticals’ share price, with a 30-day share price return of 29.01% and a 90-day share price return of 30.61%. At the same time, the year-to-date...
NasdaqGS:ASND
NasdaqGS:ASNDBiotechs

Ascendis Pharma (ASND) Could Be 30% Undervalued Following Mixed Share Price Moves

Ascendis Pharma (NasdaqGS:ASND) has drawn investor attention after recent share price swings, with the stock down about 4% over the past month but slightly higher over the past week. See our latest analysis for Ascendis Pharma. At a latest share price of $238.01, Ascendis Pharma has seen its 7 day share price return of 2.97% partially offset a 1 month share price decline of 3.66%, while the year to date share price return is down 3%. This suggests that momentum has been choppy rather than...
NasdaqGS:CHTR
NasdaqGS:CHTRMedia

Charter Communications (CHTR) Could Be 45% Undervalued As Netflix Arrives In Spectrum App Store

Charter Communications (CHTR) has drawn investor attention after allowing Spectrum customers to purchase Netflix directly through The Spectrum App Store, a move that coincides with the stock’s recent price move and changing index status. See our latest analysis for Charter Communications. The Netflix App Store launch sits against a weaker backdrop for Charter Communications, with the share price at US$131.42 and down 9.46% over 30 days and 39.86% over 90 days. The 1 year total shareholder...
NYSE:NKE
NYSE:NKELuxury

NIKE (NKE) Slides As Brand Strength Narrative Keeps Valuation In Question

NIKE (NKE) stock has come under pressure recently, with the share price down 6% over the past month and 20% over the past 3 months. This has prompted investors to reassess the company’s current valuation. See our latest analysis for NIKE. Looking beyond the recent pullback, NIKE’s share price return is down 33.91% year to date and the 5 year total shareholder return is down 70.60%. This points to fading momentum as investors reassess growth prospects and risk. If NIKE’s recent slide has you...
NYSE:AZZ
NYSE:AZZBuilding

AZZ (AZZ) Infrastructure Demand Narrative Keeps Fair Value In Focus

AZZ (AZZ) has drawn fresh attention after recent trading data highlighted its strong long term track record and sizeable metal coatings and coil coating business, prompting investors to reassess how the stock fits into their portfolios. See our latest analysis for AZZ. At a share price of $152.93, AZZ has seen firm momentum build, with a 30 day share price return of 10.90% and a 1 year total shareholder return of 69.56%, reinforcing an already strong multi year performance profile. If AZZ’s...
NYSE:VEEV
NYSE:VEEVHealthcare Services

Veeva Systems (VEEV) Stock After 42% Slide And Mixed Valuation Signals

If you are wondering whether Veeva Systems at around US$161 a share is starting to look attractively priced, you are not alone in asking that question right now. The stock has risen 4.2% over the past week and 0.7% over the past month, yet it is still down 26.5% year to date and 42.3% over the past year, which can signal shifting views on its potential and risk. Recent coverage around Veeva Systems has focused on its role as a cloud software provider to life sciences companies and how its...
NasdaqGS:GRAB
NasdaqGS:GRABTransportation

Grab Holdings (GRAB) Could Be 66% Undervalued As Its Superapp Narrative Builds

Recent Performance Snapshot for Grab Holdings Stock Grab Holdings (GRAB) has drawn investor interest after recent trading, with the stock closing at $3.49 and showing mixed returns, including a slight gain over the past week but a decline over the past 3 months. See our latest analysis for Grab Holdings. Recent trading suggests short-term momentum in Grab Holdings is still soft. The 1-day share price return is 0.87% and the 7-day share price return is 1.16%, compared with a year-to-date share...
NYSE:HPE
NYSE:HPETech

Hewlett Packard Enterprise (HPE) Could Be 24% Below Fair Value After Its AI Push

Hewlett Packard Enterprise (HPE) has put AI infrastructure and private cloud at the center of its Discover 2026 updates, tying together new data center networking, self-driving operations, and a unified partner program around its full-stack AI strategy. See our latest analysis for Hewlett Packard Enterprise. The Discover 2026 announcements arrive after a powerful run in Hewlett Packard Enterprise’s stock, with a 30 day share price return of 29.72% and a 90 day share price return of 94.46%...